Á¦³×¸¯ ÀǾàǰ ½ÃÀåÁ¶»çº¸°í¼­

Global InformationÀÌ Á¦°øÇϰí ÀÖ´Â Á¦³×¸¯ ÀǾàǰ(Generics), ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilar), ¹ÙÀÌ¿Àº£ÅÍ(Biobetter) °ü·Ã º¸°í¼­¿¡¼­´Â ÇöÀç¿Í ÇâÈÄÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ȯ°æ ºÐ¼® Á¤º¸¸¦ ÀüÇØµå¸®°í ÀÖ½À´Ï´Ù. ¶Ç ƯÇã ¸¸·á ´ëÃ¥°ú ÀǾàǰ ¼ö¸íÁֱ⠰ü¸®, ½ÃÀå ÁøÃâ ±âȸ, ½ÇÀû »óÈ£ºñ±³ µîÀÇ Á¤º¸µµ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 133°Ç)
¹ÙÀÌ¿À½Ã¹Ð·¯ °Ë»ç ¼­ºñ½º ½ÃÀå - ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø : ¼­ºñ½º À¯Çüº°, ºÐÀÚ À¯Çüº°, Ä¡·á ºÐ¾ßº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Biosimilar Testing Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service Type, By Molecule Type, By Therapeutic Area, By End User, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ºÐ¼® ¹× ¿¹Ãø(-2034³â) : À¯Çü, Á¦Ç°, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚ, ±â¼ú, ÇÁ·Î¼¼½º, ±¸¼º ¿ä¼Ò, ´Ü°è, ¼­ºñ½º, µð¹ÙÀ̽º
Biosimilars Market Analysis and Forecast to 2034: Type, Product, Application, End User, Technology, Process, Component, Stage, Services, Device
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,750 £Ü 6,635,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °áÀý¼º °æÈ­Áõ Ä¡·áÁ¦ ½ÃÀå º¸°í¼­(2025³â)
Tuberous Sclerosis Drug Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,272,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È޹̶ó ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå º¸°í¼­(2025³â)
Humira Biosimilar Global Market Report 2025
¹ßÇà 2025³â 07¿ù
°¡°Ý US $ 4,490 £Ü 6,272,000 (ºÎ°¡¼¼ º°µµ)
¶õÅõ½º(Lantus) ½ÃÀå : ¿¬·ÉÃþº°, °­µµº°, Á¦Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°
Lantus Market, By Age Group, By Strength, By Dosage Form, By End User, By Distribution Channel, By Geography
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå(-2035³â) : ¾à¹° Á¾·ù(mAbs, GCSF, Àν¶¸°, Ç×ÀÀ°íÁ¦, rhGH, Å׸®ÆÄ¶óŸÀ̵å, GLP-1), ÀûÀÀÁõ, °æÀï ±¸µµ, Áö¿ªº°
Biosimilars Market by Drug Class (mAbs, GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication, Competitive Landscape, Region - Global Forecast to 2035
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,950 £Ü 6,914,000 (ºÎ°¡¼¼ º°µµ)
Çã¼Áƾ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ¿¹Ãø(-2032³â) : À¯Çüº°, ¿ë·®º°, À¯Åë ä³Îº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ¼¼°è ºÐ¼®
Herceptin Biosimilar Market Forecasts to 2032 - Global Analysis By Type (Ogivri, Herzuma, Ontruzant, Trazimera and Other Types), Dosage, Distribution Channel, Application, End User and By Geography
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,150 £Ü 5,797,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° °¨ÀÛÁ¦ ½ÃÀå
Insulin Sensitizers
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 5,850 £Ü 8,171,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¦³×¸¯ ÀÛ¹° º¸È£ È­ÇÐÁ¦Ç° ½ÃÀå : ¿¹Ãø - À¯Çüº°, ÀÛ¹° À¯Çüº°, Á¦Á¦º°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(-2032³â)
Generic Crop Protection Chemicals Market Forecasts to 2032 - Global Analysis By Type (Herbicides, Insecticides, Fungicides and Other Types), Crop Type, Formulation, Application and By Geography
¹ßÇà 2025³â 06¿ù
°¡°Ý US $ 4,150 £Ü 5,797,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜŬ·ÐÇ×ü ½ÃÀå
Biosimilar Monoclonal Antibody
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,171,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜŬ·ÐÇ×ü ½ÃÀå : ½ÃÀå ±Ô¸ð ºÐ¼®(Á¾·ùº°, ÀûÀÀÁõº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°) ¹× ¿¹Ãø(2022-2032³â)
Global Biosimilar Monoclonal Antibodies Market Size study, by Type, by Indication, by End User, and Regional Forecasts 2022-2032
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,950 £Ü 6,914,000 (ºÎ°¡¼¼ º°µµ)
¹Ì±¹ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Ç° Ŭ·¡½ºº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ, ¿¹Ãø(2018-2032³â)
United States Biosimilars Market Assessment, By Product Class, By Indication By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 3,500 £Ü 4,889,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñÁÖ»ç Àν¶¸° ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2020-2030³â)
Non-Injectable Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ÈíÀÔ ¹× ºñ°­ ½ºÇÁ·¹ÀÌ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ±Ô¸ð ºÐ¼® : Á¦Çüº°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾»ç¿ëÀÚº°, À¯Åë ä³Îº°, Áö¿ªº°, ¿¹Ãø(2022-2032³â)
Global Inhalation And Nasal Spray Generic Drugs Market Size study, by Dosage Form, by Therapeutic Area, by End User, by Distribution Channel, and Regional Forecasts 2022-2032
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,950 £Ü 6,914,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÓÈ¿¼º Àν¶¸° ½ÃÀå º¸°í¼­(2025³â)
Short-Acting Insulin Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,272,000 (ºÎ°¡¼¼ º°µµ)
ºê·£µå Á¦³×¸¯ ½ÃÀå : ¾àÁ¦ Ŭ·¡½ºº°, ¿ëµµ, Åõ¿© °æ·Î, À¯Åë ä³Î, Áö¿ª(2026-2032³â)
Branded Generics Market By Drug Class, Application, Route of Administration, Distribution Channel, & Region for 2026-2032
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,950 £Ü 5,517,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜŬ·ÐÇ×ü ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, ¿ëµµº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Biosimilar Monoclonal Antibodies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2018-2032³â)
Insulin Market Assessment, By Product, By Type, By Application, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,800 £Ü 6,705,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå : Á¦Ç° À¯Çü, ¾àÁ¦ Ŭ·¡½ºº°, Åõ¿© °æ·Î, ȯÀÚ À¯Çü, Ä¡·á ¿ëµµ, À¯Åë ä³Î - ¿¹Ãø(2025-2030³â)
Generic Drugs Market by Product Type, Drug Class, Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,939 £Ü 5,502,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ÀÇ»çÀÇ ·»Á ÅëÇÑ Àü¸Á
Biosimilars - Through the Physician's Lens
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 1,950 £Ü 2,723,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºê·£µå Á¦³×¸¯ ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¾àÁ¦ Ŭ·¡½ºº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Branded Generics Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Class, By Application, By Distribution Channel, By Region & Competition, 2020-2030F
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
±âÀú Àν¶¸° ½ÃÀå : À¯Çüº°, Åõ¿© µð¹ÙÀ̽ºº°, ÀûÀÀÁõº°, ¿¬·ÉÃþº°, À¯Åë ä³Îº°, Áö¿ªº°
Basal Insulin Market, By Type, By Delivery Device, By Indication, By Age Group, By Distribution Channel, By Geography
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° °¨ÀÛÁ¦ ½ÃÀå : Àν¶¸° °¨ÀÛÁ¦ À¯Çüº°, ÀûÀÀÁõº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°
Insulin Sensitizers Market, By Type of Insulin Sensitizers, By Indication, By Route of Administration, By Distribution Channel, By Geography
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ È޹̶ó ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Ç° À¯Çüº°, ÀûÀÀÁõº°, À¯Åë ä³Îº°, ȯÀÚ ¿¬·Éº°, Áö¿ªº°
Humira Biosimilar Market, By Product Type, By Indication, By Distribution Channel, By Patient Age, By Geography
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 4,500 £Ü 6,286,000 (ºÎ°¡¼¼ º°µµ)
¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ¹Ì±¹ ÁöºÒÀÚÀÇ °üÁ¡
Biosimilars: US Payers' Perspective
¹ßÇà 2025³â 03¿ù
°¡°Ý US $ 8,000 £Ü 11,175,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.